A 2023 update on the advancements in the treatment of agitation in Alzheimer’s disease
Year: 2023
Type: article
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, agitation, neuropsychiatric symptoms, pharmacotherapy, non-pharmacological treatment, antipsychotic drugs, sedative-hypnotic drugs, anxiolytics, acetylcholinesterase inhibitors, NMDA receptor antagonists, antidepressants, brexpiprazole, cannabinoids, dexmedetomidine, dextromethorphan, escitalopram, prazosin, drug repurposing, neurobiological mechanisms, clinical trials
Open Access status: closed
OpenAlex ID: W4360602811
